|
Christian Conference of Asia
|
About CCA
Program Clusters: Special Programs:
|
HIV/AIDSScans used to detect HIV progression London: A scanning technique can track the progression of HIV and could lead to new treatment options and the development of the next generation of anti-AIDS drugs, scientists said on Friday. Positron emission tomography (PET) scans are usually used to identify cancerous tumours, but researchers in the United States believe the technology could play an important role in the battle against AIDS by identifying the impact of the virus on lymph nodes, which could be treated with radiotherapy or surgery. Doctor C. David Pauza and scientists at the University of Maryland Biotechnology Institute in Baltimore took whole body PET scans of 15 HIV patients and found fairly distinct sites of immune response during different stages of the illness. “We believe that if we identify those sites clearly during HIV infection we encourage people to consider these types of interventions,” Pauza said, referring to surgery or radiotherapy. During early disease, lymph nodes in the head and neck were activated, according to the PET scans, but in later stages the virus stimulated an immune response in areas of the torso and later in the bowel. HIV/AIDS is treated with antiretroviral drungs. Surgery or radiotherapy would open up a new approach to the illness that has affected 42 million people worldwide. “We are not aware that it has even been tried,” said Pauza, who reported his findings in The Lancet medical journal. “We think it is appropriate to consider these approaches and also appropriate to learn from the cancer models because cancer is a disease of chronic cell activation and growth and in some ways, even though HIV is triggered by a virus, it has some similarities.” In cancer patients, PET scans measure the activity of cancerous cells, while in HIV it picks up levels of immune system reaction. David Schwartz and Sujatha Iyengar, of the Johns Hopkins University Bloomberg School of Hygiene and Public Health, who also used PET scans to track HIV progression, said lymph node removal could give patients an opportunity for a break in antiretroviral treatment. “Although many systemic sites from which latent virus could be re-activated would be left, re-activation might not occur for months or years after removal of the active nodes,, thereby allowing extended interruption of treatment,” Schwartz said in a separate study published in the Lancet. China Daily September 20, 2003 posted by Prawate on Thursday, October 09, 2003 |
| Archives: |
|
April 2003 /
May 2003 /
June 2003 /
July 2003 /
October 2003 /
November 2003 /
January 2004 /
February 2004 /
March 2004 /
April 2004 /
May 2004 /
July 2004 /
August 2004 /
November 2004 /
December 2004 /
January 2005 /
February 2005 /
March 2005 /
July 2005 /
January 2006 /
February 2006 /
March 2006 /
June 2006 /
August 2008 /
April 2009 /
June 2009 /
November 2009 /
December 2009 /
January 2010 /
February 2010 /
May 2010 /
June 2010 /
August 2010 /
September 2010 /
October 2010 /
November 2010 /
May 2011 /
June 2011 /
August 2011 /
September 2011 /
October 2011 /
November 2011 /
December 2011 /
February 2012 /
July 2012 /
August 2012 /
November 2012 /
|
